Lra Oliphant, a director at Aehr Test Systems (NASDAQ:AEHR), sold 4,665 shares of common stock on April 16, 2026, at $85.5879 per share, for a total of $399,267.
The sale occurs after the stock’s impressive 891% rise over the past year. Shares now trade at $80.85, below Oliphant’s sale price.
Analysis reveals AEHR trades above its fair value, with a $2.55 billion market cap amid negative earnings of $0.38 per share.
Oliphant retains 18,432 shares post-sale, including unvested restricted stock units.
Record $41M Order from Hyperscale AI Customer
Aehr Test Systems secured a landmark $41 million production order from a hyperscale customer for package-level burn-in testing of custom AI processor ASICs. The company’s largest order ever includes Sonoma high-power test and burn-in systems, burn-in modules, and custom sockets. Deliveries start in fiscal 2027.
Mixed Q3 2026 Results
Aehr Test Systems posted Q3 2026 earnings per share of -$0.05, surpassing estimates of -$0.07. Revenue reached $10.3 million, missing the $10.8 million forecast.
Analyst Upgrades on Strong Bookings
Freedom Broker lifted its price target to $61 from $38, holding a Hold rating. Lake Street raised its target to $56 from $50, maintaining Buy. Analysts highlight $37.2 million in quarterly bookings and a backlog over $50 million.
These updates underscore Aehr Test Systems’ momentum with hyperscale AI clients and strategic market role.
